Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;46(3):330-337.
doi: 10.1038/bmt.2010.100. Epub 2010 May 3.

Allogeneic Hematopoietic SCT as Treatment Option for Patients With Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): A Consensus Conference Proposal for a Standardized Approach

Affiliations
Free PMC article

Allogeneic Hematopoietic SCT as Treatment Option for Patients With Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE): A Consensus Conference Proposal for a Standardized Approach

J Halter et al. Bone Marrow Transplant. .
Free PMC article

Abstract

Allogeneic hematopoietic SCT (HSCT) has been proposed as a treatment for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). HSCT has been performed in nine patients using different protocols with varying success. Based on this preliminary experience, participants of the first consensus conference propose a common approach to allogeneic HSCT in MNGIE. Standardization of the transplant protocol and the clinical and biochemical assessments will allow evaluation of the safety and efficacy of HSCT as well as optimization of therapy for patients with MNGIE.

Similar articles

See all similar articles

Cited by 44 articles

See all "Cited by" articles

Publication types

MeSH terms

Supplementary concepts

Feedback